Portage Biotech (PRTG) Stock Chart & Stock Price History $7.70 -0.33 (-4.11%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Portage Biotech Stock Price Performance The Portage Biotech (PRTG) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 19.94%, with a year-to-date return of 48.94%. In the past month, the stock has increased 34.38%, reflecting recent market activity. As of the latest close, Portage Biotech traded at $8.03 with a market cap of $8.43 million and volume of 29,824 shares. Receive PRTG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-13.09%1 Month Performance+34.38%3 Month Performance-2.41%Year-To-Date Performance+48.94%1 Year Performance+19.94% PRTG Stock Chart for Tuesday, August, 26, 2025 PRTG Chart by TradingView Portage Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$9.11$8.03-11.86%$9.08$8.0129,824 shs$8.43 million08/22/2025$8.86$9.11+2.82%$9.70$9.0015,712 shs$9.57 million08/21/2025$8.26$8.86+7.26%$9.25$8.3062,365 shs$9.30 million08/20/2025$8.00$8.26+3.25%$8.78$7.8056,236 shs$8.67 million08/19/2025$8.47$8.00-5.55%$8.39$7.5827,584 shs$8.40 million08/18/2025$8.68$8.47-2.42%$8.56$8.406,232 shs$8.89 million08/15/2025$8.80$8.68-1.36%$9.04$8.4615,155 shs$9.11 million08/14/2025$8.90$8.80-1.12%$9.16$8.2237,922 shs$9.23 million08/13/2025$8.71$8.90+2.18%$9.30$8.4716,063 shs$9.35 million08/12/2025$8.85$8.71-1.58%$9.00$8.2029,453 shs$9.15 million Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$9.30$8.85-4.84%$9.00$8.3829,796 shs$9.28 million08/08/2025$9.97$9.30-6.72%$10.06$8.08121,342 shs$9.77 million08/07/2025$8.65$9.97+15.26%$10.25$8.22135,029 shs$10.46 million08/06/2025$7.02$8.65+23.22%$8.69$7.02134,775 shs$9.08 million08/05/2025$5.87$7.02+19.59%$7.25$5.89153,563 shs$7.37 million08/04/2025$5.42$5.87+8.30%$5.87$5.3525,287 shs$6.16 million08/01/2025$5.96$5.42-9.06%$6.08$5.3020,512 shs$5.69 million07/31/2025$6.20$5.96-3.87%$6.22$5.7132,656 shs$6.26 million07/30/2025$5.70$6.20+8.77%$6.40$5.6539,429 shs$6.51 million07/29/2025$5.96$5.70-4.36%$5.97$5.705,582 shs$5.98 million07/28/2025$5.73$5.96+4.01%$5.96$5.6334,678 shs$6.26 million07/25/2025$5.94$5.73-3.45%$6.07$5.584,717 shs$6.02 million Related Companies Akari Therapeutics Stock Price Chart Clearside Biomedical Stock Price Chart Mural Oncology Stock Price Chart JATT Acquisition Stock Price Chart Synergy CHC Stock Price Chart BioXcel Therapeutics Stock Price Chart Mana Capital Acquisition Stock Price Chart Dyadic International Stock Price Chart Kezar Life Sciences Stock Price Chart MIRA Pharmaceuticals Stock Price Chart Receive PRTG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRTG) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access